Shawn M. Bowman
Net Worth
Last updated:
What is Shawn M. Bowman net worth?
The estimated net worth of Mr. Shawn M. Bowman is at least $1,995,250 as of 22 Sep 2022. He owns shares worth $574,308 as insider, has earned $115,222 from insider trading and has received compensation worth at least $1,305,720 in Sanara MedTech Inc..
What is the salary of Shawn M. Bowman?
Mr. Shawn M. Bowman salary is $326,430 per year as Co-Chief Operating Officer & Pres of Wound Care in Sanara MedTech Inc..
How old is Shawn M. Bowman?
Mr. Shawn M. Bowman is 50 years old, born in 1975.
What stocks does Shawn M. Bowman currently own?
As insider, Mr. Shawn M. Bowman owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | Co-Chief Operating Officer & Pres of Wound Care | 18,550 | $30.96 | $574,308 |
What does Sanara MedTech Inc. do?
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako's Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Shawn M. Bowman insider trading
Sanara MedTech Inc.
Mr. Shawn M. Bowman has made 5 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 340 units of SMTI stock worth $9,710 on 22 Sep 2022.
The largest trade he's ever made was exercising 1,000 units of SMTI stock on 28 Sep 2021. As of 22 Sep 2022 he still owns at least 18,550 units of SMTI stock.
Sanara MedTech key executives
Sanara MedTech Inc. executives and other stock owners filed with the SEC:
- Mr. Michael D. McNeil (59) Chief Financial Officer & Corporation Sec.
- Mr. Shawn M. Bowman (50) Co-Chief Operating Officer & Pres of Wound Care
- Mr. Zachary B. Fleming (50) Chief Executive Officer